Skip to main content
. 2020 Aug;8(15):952. doi: 10.21037/atm-20-1522

Figure 3.

Figure 3

Trend representing the use of substitutes for AVR in endocarditis from 2005 to 2011 in USA (STS database). (A) Native aortic valve endocarditis and (B) prosthetic valve endocarditis. The P value for the usage trends in both groups was <0.001. (biologic = squares; mechanical = triangles; homograft = x; other = star.). Reproduced with permission from Savage et al. (17).